ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Ibrutinib Restores Tumor-specific Adaptive Immunity in Chronic Lymphocytic Leukemia.

Clive S ZentPubMed ↗Publisher ↗

No numbers read from the abstract.